BridgeMD
Tests treatment safety and results for Social Anxiety Disorder
Official title Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
ClinicalTrials.gov ID: NCT07192367
What this study is testing
What is Sertraline (Oral Antidepressant)?
Sertraline (Oral Antidepressant) is an investigational medicine, given as an once-daily, being studied as a potential treatment for social anxiety disorder.
Also referred to as SSRI, Zoloft.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study compares two treatment approaches for adolescents and young adults with social anxiety. One group will participate in therapy sessions using a virtual reality headset, while the other group will receive sertraline, a commonly used medication for social anxiety.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- RESEARCH ARM:
- Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic
- Have normal intelligence based on clinical observation
- Be between 12 and 17 years of age
- Have a diagnosis of SAD
You likely can't join if
- RESEARCH ARM:
- Substance use disorder
- Schizophrenia and bipolar disorder
- Autism spectrum disorder
- Cognitive disability
- Neurological disorder
See the full eligibility criteria
- RESEARCH ARM:
- Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic
- Have normal intelligence based on clinical observation
- Be between 12 and 17 years of age
- Have a diagnosis of SAD
- Have refused medication recommended for SAD
- For SAD; are not currently receiving medical treatment
- Have received written consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them
- Have volunteered to participate in the study through an invitation poster presentation CONTROL ARM: 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on...
- RESEARCH ARM:
- Substance use disorder
- Schizophrenia and bipolar disorder
- Autism spectrum disorder
- Cognitive disability
- Neurological disorder
- Balance disorder
- Patients who have received SSRI treatment for SAD in the last 6 months CONTROL ARM:
- Substance use disorder
- Schizophrenia and bipolar disorder
- Autism spectrum disorder
- Cognitive disability
- Patients who have received SSRI treatment for SAD within the last 6 months -
The study team makes the final eligibility decision.
Where it's taking place
- Kocaeli, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kocaeli, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.